FDA Guidance to Help Ease Ibuprofen Oral Suspension Supply Issues
Published: 01/24/2023
Sources:
- Food and Drug Administration
Relevant To:
- All Healthcare Organizations
The U.S. Food and Drug Administration (FDA) has issued immediate-in-effect guidance on compounding certain ibuprofen products in an effort to improve the supply of ibuprofen oral suspension products amid record high demand.
The U.S. is currently experiencing a surge in three viruses: COVID-19, respiratory syncytial virus (RSV) and influenza, any of which can cause fever in young children. FDA has received reports of increased demand for pediatric fever-reducing medications, including ibupro…
Sign Up for Free Trial